Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SRX246

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Traumatic brain injury (TBI) is a leading cause of death and disability in persons under 35 years of age. In nonfatal moderate to… Expand
  • figure 1
  • figure 2
  • figure 2
  • figure 4
  • figure 4
2013
2013
SRX246 is a potent, highly selective, orally bioavailable vasopressin 1a receptor antagonist that represents a novel mechanism of… Expand
2013
2013
Background: We hypothesized that SRX246, a vasopressin V1a receptor antagonist, blocks the effect of intranasally administered… Expand
  • figure 1
  • table 1
  • table 2
  • figure 4
  • figure 2
2012
2012
SRX246 is a potent, highly selective human vasopressin V1a antagonist that crosses the blood-brain barrier in rats. CNS… Expand
  • figure 1
  • table 1